ANDOVER, N.J.--When announcing a ban on ephedra dietary supplements earlier this year, the Food and Drug Administration (FDA) left the door open for companies to challenge its decision in court--and the first company to do so is NVE Pharmaceuticals. The makers of ephedra-based Stacker 2® filed a lawsuit in U.S. District Court for the District of New Jersey to postpone FDA's ban to hear new evidence. NVE’s suit is asking the court set aside the ban because it violates the Dietary Supplement Health and Education Act (DSHEA), while setting a precedent for further damage claims to be filed against the...